New Treatment Serum For Guillain-Barre Syndrome

The elementary symptoms of Guillain-Barre syndrome (GBS) are commonly numbness or tingling (paraesthesia) in the toes and fingers, with progressive weakness in the arms and legs over the next few days. A lot of patients experience paraesthesia only in their toes and legs; others only feel symptoms on one side of the body.

In about 60 percent of the cases, an infection affecting also the lungs or the digestive area precedes the disorder. The symptoms might active in this stage, causing only compliant difficulty in walking, demanding crutches or a walking stick. All the same, sometimes the illness progresses, leading to complete paralysis of the arms and legs.

About 30 percent of people who suffer will temporarily require the help of a machine to breathe. Muscle and joint pain can be treated with over-the-counter analgesics such as aspirin. Whenever necessary, harder pain drug perhaps prescribed.

Muscle spasms or cramps can be handled with relaxants such as diazepam. A new treatment for GBS is immune serum globulin therapy. This affects using well antibodies from blood donors to assist block the adverse antibodies in the body of the person with GBS. Plasmapheresis treatment also known as plasma interchange is a type of "blood cleansing" in which destructive antibodies are removed from your blood.

Plasmapheresis consists of dispatching the liquid portion of your blood and separating it from the actual blood cells. Treatment with plasmapheresis or intravenous immunoglobulin shortens the period of time before recovery sets out by as much as 50 percent.